240 related articles for article (PubMed ID: 36501168)
1. The Effect of Prebiotics and Oral Anti-Diabetic Agents on Gut Microbiome in Patients with Type 2 Diabetes: A Systematic Review and Network Meta-Analysis of Randomised Controlled Trials.
Ojo O; Wang X; Ojo OO; Brooke J; Jiang Y; Dong Q; Thompson T
Nutrients; 2022 Dec; 14(23):. PubMed ID: 36501168
[TBL] [Abstract][Full Text] [Related]
2. The Role of Dietary Fibre in Modulating Gut Microbiota Dysbiosis in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomised Controlled Trials.
Ojo O; Feng QQ; Ojo OO; Wang XH
Nutrients; 2020 Oct; 12(11):. PubMed ID: 33113929
[TBL] [Abstract][Full Text] [Related]
3. The Effects of Almonds on Gut Microbiota, Glycometabolism, and Inflammatory Markers in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomised Controlled Trials.
Ojo O; Wang XH; Ojo OO; Adegboye ARA
Nutrients; 2021 Sep; 13(10):. PubMed ID: 34684378
[TBL] [Abstract][Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
5. The Effect of Dietary Fibre on Gut Microbiota, Lipid Profile, and Inflammatory Markers in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomised Controlled Trials.
Ojo O; Ojo OO; Zand N; Wang X
Nutrients; 2021 May; 13(6):. PubMed ID: 34073366
[TBL] [Abstract][Full Text] [Related]
6. The Effect of Dietary Glycaemic Index on Glycaemia in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Ojo O; Ojo OO; Adebowale F; Wang XH
Nutrients; 2018 Mar; 10(3):. PubMed ID: 29562676
[TBL] [Abstract][Full Text] [Related]
7. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL; Figgitt DP
Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and Safety of Metformin Versus the Other Oral Antidiabetic Drugs in Japanese Type 2 Diabetes Patients: A Network Meta-analysis.
Nishimura R; Taniguchi M; Takeshima T; Iwasaki K
Adv Ther; 2022 Jan; 39(1):632-654. PubMed ID: 34846709
[TBL] [Abstract][Full Text] [Related]
9. The effect of probiotics, prebiotics or synbiotics on metabolic outcomes in individuals with diabetes: a systematic review and meta-analysis.
Bock PM; Telo GH; Ramalho R; Sbaraini M; Leivas G; Martins AF; Schaan BD
Diabetologia; 2021 Jan; 64(1):26-41. PubMed ID: 33047170
[TBL] [Abstract][Full Text] [Related]
10. The Effect of Microbiome Therapies on Waist Circumference, a Measure of Central Obesity, in Patients with Type 2 Diabetes: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
Vazquez-Marroquin G; Ochoa-Précoma R; Porchia LM; Pérez-Fuentes R; Nicolás-Toledo L; Rodríguez-Antolín J; Gonzalez-Mejia ME
J Acad Nutr Diet; 2023 Jun; 123(6):933-952.e1. PubMed ID: 36634870
[TBL] [Abstract][Full Text] [Related]
11. Insulin secretagogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus.
Hemmingsen B; Sonne DP; Metzendorf MI; Richter B
Cochrane Database Syst Rev; 2016 Oct; 10(10):CD012151. PubMed ID: 27749986
[TBL] [Abstract][Full Text] [Related]
12. The Effect of Diabetes-Specific Enteral Nutrition Formula on Cardiometabolic Parameters in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomised Controlled Trials.
Ojo O; Weldon SM; Thompson T; Crockett R; Wang XH
Nutrients; 2019 Aug; 11(8):. PubMed ID: 31443185
[TBL] [Abstract][Full Text] [Related]
13. The effect of microbiome-modulating probiotics, prebiotics and synbiotics on glucose homeostasis in type 2 diabetes: A systematic review, meta-analysis, and meta-regression of clinical trials.
Paul P; Kaul R; Harfouche M; Arabi M; Al-Najjar Y; Sarkar A; Saliba R; Chaari A
Pharmacol Res; 2022 Nov; 185():106520. PubMed ID: 36272640
[TBL] [Abstract][Full Text] [Related]
14. Psychological interventions to improve self-management of type 1 and type 2 diabetes: a systematic review.
Winkley K; Upsher R; Stahl D; Pollard D; Kasera A; Brennan A; Heller S; Ismail K
Health Technol Assess; 2020 Jun; 24(28):1-232. PubMed ID: 32568666
[TBL] [Abstract][Full Text] [Related]
15. Impact of antidiabetic agents on dementia risk: A Bayesian network meta-analysis.
Zhou JB; Tang X; Han M; Yang J; Simó R
Metabolism; 2020 Aug; 109():154265. PubMed ID: 32446679
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular safety and efficacy of metformin-SGLT2i versus metformin-sulfonylureas in type 2 diabetes: systematic review and meta-analysis of randomized controlled trials.
Gebrie D; Getnet D; Manyazewal T
Sci Rep; 2021 Jan; 11(1):137. PubMed ID: 33420333
[TBL] [Abstract][Full Text] [Related]
17. Combined effects of
Shin NR; Gu N; Choi HS; Kim H
Am J Physiol Endocrinol Metab; 2020 Jan; 318(1):E52-E61. PubMed ID: 31770016
[TBL] [Abstract][Full Text] [Related]
18. Effect of Ramadan fasting on glycaemic parameters & body mass index in type II diabetic patients: A meta-analysis.
Aydin N; Kul S; Karadağ G; Tabur S; Araz M
Indian J Med Res; 2019 Dec; 150(6):546-556. PubMed ID: 32048618
[TBL] [Abstract][Full Text] [Related]
19. Comparison of glucose-lowering agents after dual therapy failure in type 2 diabetes: A systematic review and network meta-analysis of randomized controlled trials.
Zaccardi F; Dhalwani NN; Dales J; Mani H; Khunti K; Davies MJ; Webb DR
Diabetes Obes Metab; 2018 Apr; 20(4):985-997. PubMed ID: 29205774
[TBL] [Abstract][Full Text] [Related]
20. Comparative efficacy and safety of antidiabetic drug regimens added to metformin monotherapy in patients with type 2 diabetes: a network meta-analysis.
Mearns ES; Sobieraj DM; White CM; Saulsberry WJ; Kohn CG; Doleh Y; Zaccaro E; Coleman CI
PLoS One; 2015; 10(4):e0125879. PubMed ID: 25919293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
